HIV/AIDS: Diagnosis and Management

Written by Dr. Muhammad Salar Raza · Manually reviewed by Dr. Muhammad Salar Raza · Content updated

Clinical Pathway

AIDS (Acquired Immunodeficiency Syndrome) is the final, most severe stage of HIV infection, characterized by a profoundly compromised immune system that makes individuals highly susceptible to opportunistic infections and certain cancers. It is diagnosed when the CD4+ T-cell count drops below 200 cells/mm³ or when specific AIDS-defining opportunistic illnesses develop. The cornerstone of AIDS treatment is highly active antiretroviral therapy (HAART), a combination of drugs that suppress HIV replication, preserve immune function, and prevent further progression. HAART significantly reduces viral load, increases CD4+ T-cell counts, and improves overall health. Treatment also includes prophylactic antibiotics to prevent opportunistic infections and specific therapies for any active infections or cancers. Symptoms of AIDS are primarily due to the opportunistic infections and cancers that take advantage of the severely weakened immune system. Common manifestations include persistent fever, chronic diarrhea, significant unintentional weight loss, night sweats, fatigue, swollen lymph nodes, and recurrent severe infections like Pneumocystis pneumonia, Kaposi's sarcoma, and toxoplasmosis. Neurological complications such as AIDS dementia complex can also occur.

Clinical Reasoning

AIDS develops as a direct consequence of untreated or late-stage Human Immunodeficiency Virus (HIV) infection. HIV primarily targets and progressively destroys CD4+ T-lymphocytes, which are critical for coordinating the immune response. This progressive depletion leads to a severe immunodeficiency, rendering the body unable to effectively fight off pathogens that would normally be harmless. With timely diagnosis and consistent adherence to antiretroviral therapy (ART), people living with HIV can prevent progression to AIDS and live long, healthy lives, often with a near-normal life expectancy. However, without treatment, AIDS is ultimately fatal, typically within a few years due to severe opportunistic infections or cancers. Unprotected sexual contact (vaginal, anal, oral) with an infected person.,Sharing contaminated needles or syringes (e.g., for intravenous drug use).,Perinatal transmission from mother to child during pregnancy, childbirth, or breastfeeding.,Receiving contaminated blood transfusions or organ transplants (rare in countries with robust screening).,Needle-stick injuries or exposure to infected blood in healthcare settings (occupational risk).

Sample MCQ

A patient diagnosed with Human Immunodeficiency Virus (HIV) exhibits progressive immunodeficiency, characterized by a significantly increased susceptibility to opportunistic infections. This heightened risk of infection is primarily due to a deficiency of which of the following:

  • ACD8+ T lymphocytes
  • BCD4+ T lymphocytes
  • CB lymphocytes
  • DNatural killer (NK) cells

Correct Answer: CD4+ T lymphocytes

### TLDR HIV primarily targets and destroys **CD4+ T lymphocytes**, which are central orchestrators of the adaptive immune response. This progressive depletion cripples cell-mediated immunity, leading to profound immunodeficiency and a significantly increased susceptibility to opportunistic infections characteristic of AIDS. ### Comparison Table | Option | Mechanism | Clinical Nuance | Key Distinction | |---|---|---|---| | CD8+ T lymphocytes | Kill virus-infected cells. | Important for viral control. | Not primarily depleted by HIV. | | **CD4+ T lymphocytes** | Coordinate immune responses. | Depletion causes immunodeficiency. | **Main HIV target; progressive loss.** | | B lymphocytes | Produce antibodies. | Antibody production can be impaired. | Not directly targeted or destroyed. | | Natural killer (NK) cells | Kill infected/tumor cells. | Crucial for early viral defense. | Not primary cause of profound immunodeficiency. | ### Detailed Breakdown The correct answer is **CD4+ T lymphocytes**. **CD4+ T lymphocytes**, also known as helper T cells, are paramount orchestrators of the adaptive immune system. They recognize antigens presented by antigen-presenting cells and then activate other crucial immune cells, including B lymphocytes (to produce antibodies) and cytotoxic CD8+ T lymphocytes (to kill infected cells). HIV specifically targets and infects **CD4+ T lymphocytes** by binding to the CD4 receptor and co-receptors (CCR5 or CXCR4) on their surface. Once infected, these cells are progressively destroyed, either directly by viral replication, by cytotoxic T cells recognizing viral antigens, or through programmed cell death (apoptosis). The relentless and progressive destruction of **CD4+ T lymphocytes** is the hallmark of HIV infection. As their count drops below critical thresholds (e.g., typically below 200 cells/µL), the immune system's ability to mount effective responses against various pathogens is severely compromised. This profound immunodeficiency primarily affects cell-mediated immunity, leaving the body highly susceptible to opportunistic infections, which are typically controlled by a healthy immune system. Examples include *Pneumocystis jirovecii* pneumonia, *Toxoplasma gondii* encephalitis, and *Mycobacterium avium* complex infections. While other immune cells are involved in HIV pathogenesis and their functions can be altered: * **CD8+ T lymphocytes** (cytotoxic T cells) are crucial for killing virus-infected cells, including HIV-infected cells, and are part of the host's defense. HIV does not primarily deplete them; rather, their function might be impaired due to the lack of help from **CD4+ T lymphocytes**. * **B lymphocytes** produce antibodies. While some B cell dysfunction and hypergammaglobulinemia can occur in advanced HIV, they are not directly targeted and destroyed by HIV, nor is their deficiency the primary cause of the broad range of opportunistic infections characteristic of AIDS. * **Natural killer (NK) cells** are part of the innate immune system, providing early defense against viral infections and tumors. While their function can be altered in HIV, their deficiency is not the fundamental cause of the progressive immunodeficiency and susceptibility to the specific opportunistic infections seen in AIDS, which largely stems from a failure of adaptive immunity spearheaded by **CD4+ T lymphocytes**.

Guidelines and further reading

Related Clinical Topics

Septic Shock: Recognition and Management

Septic shock is a life-threatening condition characterized by circulatory, cellular, and metabolic abnormalities that are profound enough to substantially increase mortality, stemming from a dysregulated host response to infection. It is a subset of sepsis where patients require vasopressors to maintain an adequate mean arterial pressure and have elevated serum lactate despite adequate fluid resuscitation. Immediate management involves rapid administration of broad-spectrum antibiotics, aggressive intravenous fluid resuscitation (typically crystalloids), and vasopressors (e.g., norepinephrine) to restore and maintain adequate blood pressure and organ perfusion. Source control of infection (e.g., drainage of abscess, removal of infected device) is critical. Supportive care, including mechanical ventilation, renal replacement therapy, and glycemic control, is often required. Patients present with signs of severe infection and profound circulatory dysfunction, including persistent hypotension requiring vasopressors to maintain a mean arterial pressure of 65 mmHg or greater, despite adequate fluid resuscitation, and a serum lactate level > 2 mmol/L. Other manifestations of organ dysfunction may include altered mental status, oliguria, tachycardia, tachypnea, fever or hypothermia, and mottled skin.

Urosepsis: Diagnosis and Management

Urosepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection originating from the urinary tract. It represents a severe systemic inflammatory response syndrome (SIRS) triggered by a urinary tract infection (UTI). Treatment involves immediate initiation of broad-spectrum intravenous antibiotics, empirically selected to cover common uropathogens, and subsequently narrowed based on culture sensitivities. Aggressive supportive care, including intravenous fluid resuscitation to correct hypotension, and vasopressors if needed, is crucial to maintain organ perfusion. Source control, such as removal of an obstructed catheter or drainage of a collection, is also a critical component of management. Patients commonly present with signs of systemic infection, including high fever, chills, tachycardia, and hypotension. They may also exhibit symptoms related to the urinary source, such as dysuria, flank pain, urgency, or suprapubic tenderness. Signs of organ dysfunction like altered mental status, oliguria, tachypnea, or mottled skin may also be present, indicating severe sepsis or septic shock.

Community-Acquired Pneumonia (CAP): Diagnosis and Management

Suspect CAP in patients with cough, fever, sputum, and focal chest signs, and confirm with a chest radiograph showing new infiltrate. Stratify severity with CURB-65 (confusion, urea, respiratory rate, blood pressure, age 65 or older). Low-risk patients are treated as outpatients with amoxicillin, adding or substituting a macrolide for atypical coverage where appropriate. Patients admitted to the ward receive a beta-lactam such as ceftriaxone plus a macrolide such as azithromycin, while severe CAP requiring ICU care needs broader coverage and exclusion of resistant pathogens. Give antibiotics within 4 hours, support oxygenation, and reassess at 48-72 hours.

SMLE Preparation Resources

Master the 2026 SMLE

Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.

Try the QBank & Scaled Mocks